Zymofix funding news – Ghent-based Zymofix Raises €2 Million in Funding
Nov 12, 2024 | By Kailee Rainse
Zymofix, a company specializing in industrial biotechnology, has raised €2 million in funding. The investment was led by High-Tech Gründerfonds (HTGF), with additional participation from The Nest Family Office and VP Capital.
SUMMARY
- Zymofix, a company specializing in industrial biotechnology, has raised €2 million in funding.
- Zymofix scales the production of beneficial microorganisms for agriculture and technical applications by fermenting biomass residues.
This funding will help it to expand its fermentation technology, which turns biomass waste into microorganisms for use in agriculture and industry.
Previously known as N-Fix, it uses a unique fermentation process to turn biomass waste into microorganisms that improve soil health, boost crop yields, and reduce environmental impact.
Read also - Oriole Networks funding news – London-based Oriole Networks Secures an Additional €20.2 Million Funding
RECOMMENDED FOR YOU
Getir funding news – Food Delivery Startup Getir Secures $250 Million in Funding
Team SR
Jun 25, 2024
The company’s method uses affordable, locally sourced biomass, helping lower production costs and create cost-effective microbial solutions for crops like maize, wheat, and sugar beet.
Emile Redant, CEO of Zymofix, commented: “Our mission is to scale the production of beneficial microorganisms, transforming waste into valuable resources that foster ecosystem regeneration. This investment will enable us to bring our high-quality, scalable bio solutions to market faster and drive positive impact on planetary health.”
Scaling technology with strategic investment
The €2 million funding will help it to grow its fermentation technology and start new business partnerships. The company also plans to hire four more people in R&D and project management to support its expansion.
Guy De Clercq, Co-founder and Chairman of Zymofix’s Board of Directors, stated: “It’s incredibly rewarding to see it mature into the company it is today. We are particularly thrilled to welcome our valued investors—HTGF, The Nest, and VP Capital—whose focus on sustainable growth perfectly aligns with our mission. Their support will be instrumental in helping us scale our technology and achieve our long-term vision of transforming agriculture and industrial processes through microbial innovation.”
Investors committed to a sustainable future
Natalya Baltrukovich, Investment Manager at HTGF, said: “Zymofix has developed a unique technology platform that transforms low-value biomass residues into high-quality microorganisms with a broad range of applications. Their scalable solutions are a prime example of circular economy principles in action, and we’re confident in both the disruptive potential of the technology and the team’s ability to execute.”
Mathijs van der Knaap Investment Manager at VP Capital, added: “At VP Capital, we believe that by investing in these types of innovative circular solutions, we can accelerate positive impact for a better future for generations to come. Zymofix’s approach to transforming biomass residues into valuable microbial products aligns perfectly with our aim to foster much-needed ecological solutions.”
Hallie Fox, Senior Investment Associate of The Nest, remarked: “We are thrilled to partner with Zymofix in their journey to reshape agriculture through circular solutions. By turning waste into resources Zymofix exemplifies the resilience and innovation essential for building a healthier and more sustainable food system.”
Annick Verween, Head of Biotope by VIB and Zymofix Board Member, said: “Zymofix’s journey from concept to commercialization has been truly inspiring. Their commitment to turning waste into sustainable, high-impact solutions based on solid science perfectly aligns with our mission of nurturing impactful biotech innovations.”
About Zymofix
Zymofix scales the production of beneficial microorganisms for agriculture and technical applications by fermenting biomass residues. They are on a mission to create macro solutions that rebalance ecosystems and play a key role in improving planetary health. They explore new frontiers in industrial biotechnology.